Selenocystamine dihydrochloride (0.003 mm) inhibited particle-associated RNA-dependent RNA polymerase activity of influenza B/LEE/40, influenza A/WSN/34 (H0 N1), A/RI-5+ (H2 N2), recombinant A/RI-5+ (N2)-A/WSN/34 (H0) and recombinant A/KOREA/68 (H2)-A/BEL (N1) in vitro. The structurally related compounds L-cystine, cystamine and N,N′-diacetyl selenocystamine were less active and inhibited influenza B/LEE particle-associated RNA-dependent RNA polymerase activity by 50% at concentrations of >0.3, 0.3 and 0.018 mm, respectively. Particle-associated RNA-dependent RNA polymerase activity was inhibited immediately by addition of selenocystamine. The inhibitory activity of 0.01 mm-selenocystamine was reversed completely by the addition of 0.06 mm-β-mercaptoethanol and partially by dialysis of a virus-selenocystamine mixture. High concentrations (3 mm) of the compound had no detectable effect on influenza virus haemagglutinin or neuraminidase activities, but virus infectivity was reduced significantly after incubation with 0.03 mm-selenocystamine.
BishopD. H. L.,
ObijeskiJ. F.,
SimpsonR. W.1971; Transcription of the influenza ribonucleic acid genome by a virion polymerase. II. Nature of the in vitro polymerase product. Journal of Virology 8:74–80
ChowN. L.,
SimpsonR. W.1971; RNA dependent RNA polymerase activity associated with virions and subviral particles of myxoviruses. Proceedings of the National Academy of Science of the United States of America 68:752–756
CompansR. W.,
KlenkH. D.,
CaliguiriL. A.,
ChoppinP. W.1970; Influenza virus proteins. I. Analysis of polypeptides of the virion and identification of spike glycoproteins. Virology 42:880–889
HOP. P. K.,
WaltersC. P., StreightoffF.,
BakerL. A.,
DelongD. C.1967; In Vivo activity of an inhibitor of influenza virus induced ribonucleic acid polymerase. Antimicrobial Agents and Chemotherapy636–641